1,3-dipropyl-8-cyclopentylxanthine has been researched along with hypoxanthine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Richardt, G; Schreieck, J | 1 |
| Headrick, JP; Peart, J | 1 |
| Danielyan, L; Kloor, D; Osswald, H | 1 |
3 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and hypoxanthine
| Article | Year |
|---|---|
Endogenous adenosine reduces the occurrence of ischemia-induced ventricular fibrillation in rat heart.
Topics: Adenine; Adenosine; Aminoimidazole Carboxamide; Animals; Caffeine; Creatine Kinase; Electrocardiography; Enzyme Inhibitors; Hypoxanthine; Inosine; Male; Myocardial Ischemia; Myocardium; Perfusion; Rats; Rats, Wistar; Reperfusion Injury; Ribonucleosides; Theophylline; Thioinosine; Thiophenes; Time Factors; Ventricular Fibrillation; Xanthines | 1999 |
Intrinsic A(1) adenosine receptor activation during ischemia or reperfusion improves recovery in mouse hearts.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Creatine; Extracellular Space; Heart Function Tests; Heart Rate; Hypoxanthine; In Vitro Techniques; Inosine; Male; Mice; Mice, Inbred C57BL; Microdialysis; Myocardial Ischemia; Myocardium; Phosphocreatine; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Recovery of Function; Reperfusion; Reperfusion Injury; Xanthines | 2000 |
Characterization of the cAMP binding site of purified S-adenosyl-homocysteine hydrolase from bovine kidney.
Topics: Adenosylhomocysteinase; Animals; Binding Sites; Cattle; Cyclic AMP; Hydrolases; Hypoxanthine; Kidney; Theophylline; Tritium; Xanthines | 2002 |